The pronounced sex bias in age-related somatic hypermutation (SHM) decline—where males show steeper reductions in Phase II repair activity and mismatch repair (MMR) gene expression (Aged males exhibit a more pronounced decline in SHM-related DNA repair activities compared to females)—points to a specific, testable mechanistic failure beyond general B-cell dysfunction. Current models attribute SHM decline to diminished AID function and extrinsic GC dysfunction (Age-associated dysfunction in germinal centers contributes to poor affinity maturation and reduced class-switching). However, these models don't adequately explain why the MMR-dependent Phase II (targeting A/T bases) is disproportionately affected in males.

Hypothesis: The sex-biased decline in SHM is driven by cumulative, sex-specific oxidative damage to key MMR proteins (particularly MSH2-MSH6 and PMS2-POLη complexes) in male B cells, reducing their recruitment and processivity at AID-induced lesions. This is compounded by a relative deficit in oxidative stress defense pathways within male GC B cells, leading to the accumulation of irreversible protein adducts (e.g., 4-hydroxynonenal [4-HNE] modifications) on MMR components.

Novel Mechanistic Reasoning:

1. Oxidative Protein Modification as a Specific Driver: SHM occurs in the oxidative environment of the GC. MMR proteins are redox-sensitive. Males, due to hormonal differences (e.g., lower estrogen, which has antioxidant and DNA repair-enhancing effects), likely have a lower basal antioxidant capacity in lymphoid tissues. This makes MMR complexes in male B cells more susceptible to permanent oxidative adduction over a lifetime of GC reactions. 4-HNE adducts on MSH6, for example, would impair its binding to AID-generated mismatches, stalling the entire downstream error-prone repair cascade.
2. Decoupling from E2A/E47 Transcriptional Decline: While E2A/E47 downregulation contributes to reduced B-cell production (Aging narrows B cell repertoire diversity through reduced bone marrow production and the accumulation of antigen-experienced cells at the expense of naive cells), the functional decline in SHM repair may be more directly linked to post-translational damage to the repair machinery itself. This explains why SHM quality deteriorates even in B cells that successfully undergo GC reactions.
3. A Link to Inflammaging: Chronic low-grade inflammation increases systemic oxidative stress. This creates a vicious cycle: inflammaging generates reactive oxygen species (ROS), which damage MMR proteins in B cells, leading to poor affinity maturation and the production of lower-affinity, polyreactive antibodies (The age-related shift in the antibody repertoire includes an increase in low-affinity, polyreactive IgM from B1 cells and autoreactive clones), which further fuel inflammation.

Testable Predictions:

• Proteomic Analysis: Immunoprecipitate MMR complexes (MSH2, MSH6, PMS2) from sorted aged male vs. female GC B cells. Mass spectrometry will reveal a significantly higher burden of oxidative modifications (e.g., carbonylation, 4-HNE adducts) in male samples.
• Functional Assay: Isolate nuclei from aged male/female B cells post-stimulation. Perform an in vitro SHM assay with a defined AID target. Male-derived nuclei will show reduced incorporation of A/T mutations, but this defect can be partially rescued by supplementing the reaction with recombinant, unmodified MMR proteins.
• Intervention Study: Treat aged male mice with a targeted antioxidant (e.g., mitoTEMPO) during an immune challenge. This should selectively improve Phase II SHM efficiency and antibody affinity, bringing male parameters closer to those of aged females, without necessarily increasing overall B-cell numbers.

Contrast with Alternative Explanations: This hypothesis moves beyond simply cataloging transcriptional declines. It posits a structural failure of the MMR machinery as a proximate cause of the sex-biased SHM phenotype, directly linking the inflammatory environment of aging to a specific molecular lesion in antibody diversification.